In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more.
-
Contains 15 relevant, practice-oriented topics including lung cancer screening; advances in surgical techniques for lung cancer; non-surgical therapy for early-stage lung cancer; locally advanced lung cancer; what’s new in small cell lung cancer; and more.
-
Provides in-depth clinical reviews on lung cancer, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
State of the Art of Pathologic and Molecular Testing
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung
Cancer
Advances in Surgical Techniques for Lung Cancer
Nonsurgical Therapy for Early-Stage Lung Cancer
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung
Cancer
Locally Advanced Lung Cancer
First-Line Treatment of Driver-Negative Non-Small Cell Lung Cancer
Targeted Therapy for Non-Small Cell Lung Cancer: First Line and Beyond
What Is New in Small Cell Lung Cancer
Lung Cancer Supportive Care and Symptom Management
New Therapies on the Horizon
